Geisinger Clinic
Danville, Pennsylvania, 17822, United States
NCT Number: NCT05492786
The purpose of this study is to assess, prospectively, the effect on flu vaccination rates of salient alerts in the electronic health record that indicate a patient's high risk for flu and its complications. The investigators hypothesize that the salient alerts will lead to increased flu vaccination compared with a standard flu alert.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Danville, Pennsylvania, 17822, United States
The CDC (Centers for Disease Control) recommends a flu vaccination to everyone aged 6+ months, with rare exception; almost anyone can benefit from the vaccine, which can reduce illnesses, missed work, hospitalizations, and death. One barrier to vaccination is a lack of "cues to action," and, in particular, the lack of direct recommendation from medical personnel; this barrier is arguably the most effectively overcome by a simple nudge of clinicians, compared with barriers such as negative attitudes toward vaccination, low perceived utility of vaccination, and less experience with having received the vaccine.
Geisinger partnered with Medial EarlySign (Medial) to develop a machine learning (ML) algorithm to help identify people at risk for serious flu-associated complications based on existing electronic health record data. Eligible at-risk patients will be randomized to an active control group (clinician will be shown a standard flu alert) or one of two experimental groups (clinician will be shown an alert indicating patient's high risk, with or without describing the patient's factors contributing to that risk).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Patient Inclusion Criteria:
Clinician Inclusion Criteria:
Non-interruptive best practice alert in the electronic health record
Larger alert header and body font size, use of different font colors and boldface
Alert header indicates patient is at high risk for flu and its complications; alert body indicates the percentage of risk (e.g., in the top 3% of risk)
Alert body indicates the top 3 factors contributing to the high risk
Time frame: At the 1 day visit
Patient received a flu vaccine (yes/no)
Time frame: Up to 8 months
Patient received a flu diagnosis via a positive polymerase chain reaction [PCR]/antigen/molecular test (yes/no) during the 2022-23 flu season (from the patient's appointment date through April 30, 2023)
Time frame: Up to 8 months
Received a "high confidence flu" diagnosis (with positive polymerase chain reaction [PCR]/antigen/molecular test) and/or "likely flu" diagnosis (as assessed via International Classification of Disease [ICD] codes or Tamiflu administration or positive PCR/antigen/molecular test) (yes/no) during the 2022-23 flu season (from the patient's appointment date through April 30, 2023)
Note that "likely flu" is a superset of the "high confidence flu" diagnoses.
Time frame: Up to 8 months
Diagnosed with flu-related complications (yes/no) during the 2022-23 flu season (from the patient's appointment date through April 30, 2023)
Time frame: Up to 11 months
Number of ER visits from the patient's message appointment date through July 31, 2023
Time frame: Up to 11 months
Number of hospitalizations from the patient's message appointment date through July 31, 2023
Time frame: Up to 8 months
Received at least one COVID-19 vaccination (yes/no) during the 2022-23 flu season (from the patient's appointment date through April 30, 2023)
Time frame: Up to 8 months
Patient receives a flu vaccine (yes/no) during the 2022-23 flu season (from the patient's appointment date through April 30, 2023)
Time frame: At the 1 day visit
Patient received a flu vaccine (yes/no)
Time frame: At the 1 day visit
Patient received a flu vaccine (yes/no)
Time frame: At the 1 day visit
Patient received a flu vaccine (yes/no)
Geisinger Clinic
Other
Alerts With Risk Information to Increase Influenza Vaccinations
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05493787
Behavior, Health Behavior
Danville, Pennsylvania, United States
View Trial DetailsNCT05508698
Behavior, Health Behavior
Danville, Pennsylvania, United States
View Trial DetailsNCT06600490
Behavior, Behavior and Behavior Mechanisms
Hellerup, Capital Region, Denmark
View Trial DetailsNCT06124131
Behavior, COVID-19
New Orleans, Louisiana, United States
View Trial Details